alexa
Reach Us +44-1625-708989
Relowering Sodium After Overcorrection Of Chronic Hyponatremia: Save The Brain | 9154
ISSN: 2161-0959

Journal of Nephrology & Therapeutics
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Relowering sodium after overcorrection of chronic hyponatremia: Save the brain

2nd International Conference on Nephrology & Therapeutics

Alain Soupart

ScientificTracks Abstracts: J Nephrol Therapeutic

DOI: 10.4172/2161-0959.S1.009

Abstract
O vercorrection of severe chronic hyponatremia can lead to the osmotic demyelination syndrome (ODS), a serious neurological complication potentially leading to catastrophic neurological complications or death. The exact incidence of this complication is unknown but is probably >30% and it increases with the level of overcorrection. Brain adapts to changes in environmental osmolality and if correction is too fast, excessive brain dehydration and ODS occurs. Overcorrection is now considered as a medical emergency. No treatment is available. In animal study we showed that relowering the serum sodium (SNa) with DDAVP (desmopressin acetate) and hypotonic fluids in overcorrected rats dramatically reduced the incidence of ODS (9% vs 100%) and mortality (4% vs 80%). The benefit of this rescue manoeuvre is still obvious in symptomatic animals (ODS: 30% vs 100%; mortality: 53% vs 92%). However, clinical experience with this therapeutic approach is limited. We present a series of 14 patients with severe hyponatremia of various origins who were overcorrected and in whom sodium was relowered by combining DDAVP and hypotonic fluids. Seven cases were asymptomatic at time of sodium relowering (Group I) and 7 others present previous neurological manifestations (Group II). In group I, mean ∆ SNa was 16?3 mEq/l/24hr at time of sodium relowering. Serum sodium level fell by -6?1 mEq/l after DDAVP and hypotonic fluids administration. In group II, ∆ SNa was 15?5 mEq/l/24hr and mean decrease of serum sodium was -9 mEq/l and final correction was ∆ SNa 12?3 mEq/l/24hr. In both groups all patients recovered without neurological sequellae. We conclude that sodium relowering in patients with overcorrection of hyponatremia is an effective rescue manoeuver to prevent ODS, even when neurologic symptoms are already present
Biography
Alain Soupart has completed his Ph.D. from the Free University of Brussels and is a graduate in Internal Medicine (Erasmus University Hospital, ULB). He is co-director of the Research Unit for Hydromineral Metabolism, Free University of Brussels, Belgium. He has published more than 60 papers in peer review journals
Relevant Topics
Top